Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 338,549 | 0 | 0 | 0 | 68 |
| Other current assets | 0 | 0 | 0 | 0 | 35 |
| TOTAL | $342,137 | $0 | $0 | $0 | $103 |
| Non-Current Assets | |||||
| PPE Net | 75 | N/A | N/A | N/A | 26 |
| Other Non-Current Assets | 510 | 0 | 0 | 0 | 3 |
| TOTAL | $585 | $N/A | $N/A | $N/A | $29 |
| Total Assets | $342,722 | $0 | $0 | $0 | $132 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 719 | 0 | 0 | 0 | 935 |
| Other current liabilities | 3,866 | 0 | 0 | 0 | 443 |
| TOTAL | $4,585 | $0 | $0 | $0 | $1,378 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,585 | $0 | $0 | $0 | $1,378 |
| Shareholders' Equity | |||||
| Common Shares | 3 | 0 | 0 | 0 | 0 |
| Retained earnings | -33,094 | 0 | 0 | 0 | -10,762 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 9,348 |
| TOTAL | $338,137 | $0 | $0 | $0 | $-1,246 |
| Total Liabilities And Equity | $342,722 | $0 | $0 | $0 | $132 |